https://www.selleckchem.com/pr....oducts/baricitinib-l
The median wait time was 78.5 days (IQR 83.5). The most common cause of delay was the lack of available spots in the PsA clinic. The majority of PsA patients at the TWH PsA Clinic were not seen within the wait-time recommendation. The most common factor that prevented a timely consultation with a rheumatologist was the lack of spots in the PsA clinic. Greater access to rheumatologists can improve the timely and effective care of PsA patients. Although most studies believe that systematic biopsy (S and targeted biopsy (TB
Like
Comment
Share
